Topadur Pharma

Zurich-Schlieren, Switzerland, 7 September 2023

We are thrilled to announce that TOPADUR Pharma AG has once again been recognized as one of Switzerland's top 25 scale-up companies.

This achievement is a demonstration to our team's dedication and our partners' support.

We are grateful for this recognition and remain committed to pushing the boundaries of innovation in the years to come.

Please check out the link below.

‍

23.3.22

Press Release

European Patent Office to Grant TOPADUR’s Patent Application for TOP-N53

The European Patent Office granted a patent covering the lead drug candidate, TOP-N53 used for the treatment of chronic wounds.

8.9.22

News

We are proud to be recognized as one of Switzerland's most promising scale-ups in 2022.

8.10.20

News

The Switzerland Global Enterprise interviewed Reto Naef, CEO of TOPADUR PHARMA AG.